The federal government’s 340B Drug Pricing Program is designed to deliver significant drug price savings to eligible health care organizations and their patients. Please join WHS Industry Partner SUNRx and their special guest speaker Jeff Davis of Baker Donelson on March 10 from 11 a.m. to 12 p.m. to learn about present regulatory and compliance insights for hospitals to consider when managing their 340B programs. Information presented will empower hospitals to position their entity for the changes currently being explored in the 340B marketplace. Jeff Davis is Senior Advisor in Baker Donelson’s Government Relations and Public Policy Group. He provides clients with health care regulatory counsel on issues affecting health care providers on a variety of issues related to 340B compliance.
To register for this webinar please click here.